Pictet Asset Management (Switzerland)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$6.8M Buy
+167,274
New +$6.82M 0.01% 709

Other funds holding LKFT

Pictet Asset Management (Switzerland)'s LKFT Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2023: 167,274 shares worth $6.8M. The stake represents 0.01% of the portfolio and ranks #709 among its holdings.

76 funds tracked by Wall St. Rank hold LKFT as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 167,274 shares of Lakefront Biotherapeutics American Depositary Shares worth $6.8M as of Q2 2023.
  • Lakefront Biotherapeutics American Depositary Shares was a new Pictet Asset Management (Switzerland) position in Q2 2023.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #709 holding.
  • 76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.